News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Ashar Bhavesh
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/05/2023 |
4
| Ashar Bhavesh (Chief Commercial Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,375 shares
@ $25.25, valued at
$34.7k
|
|
| 01/09/2023 |
4
| Ashar Bhavesh (Chief Commercial Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 22,663 shares
@ $0
Paid exercise price by delivering 1,665 shares
@ $27.52, valued at
$45.8k
Granted 70,000 options to buy
@ $27.64, valued at
$1.9M
|
|
| 10/13/2022 |
4
| Ashar Bhavesh (Chief Commercial Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,464 shares
@ $56.9, valued at
$83.3k
Granted 100,000 options to buy
@ $26.98, valued at
$2.7M
|
|
| 01/10/2022 |
4
| Ashar Bhavesh (Chief Commercial Officer) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 13,062 shares
@ $0
Granted 40,710 options to buy
@ $59.46, valued at
$2.4M
|
|
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|